Optimal governance of and stakeholder involvement in a medicines regulatory authority to enable pharmaceutical innovation
The South African medicines regulatory authority will shortly be moving from under the control of the National Department of Health to become a Section 3A public entity with its own governance structure. This presents the ideal opportunity to address the urgent need for evaluation of stakeholder...
Main Author: | Calder, Amanda |
---|---|
Other Authors: | Sutherland, Margie |
Language: | en |
Published: |
University of Pretoria
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/2263/59740 Calder, A 2017, Optimal governance of and stakeholder involvement in a medicines regulatory authority to enable pharmaceutical innovation, MBA Mini Dissertation, University of Pretoria, Pretoria, viewed yymmdd <http://hdl.handle.net/2263/59740> |
Similar Items
-
Stakeholder views on data governance components, objectives, accountability, enablers and inhibitors within the banking industry in South Africa
by: Seboka, Nthabiseng
Published: (2016) -
Middle management, enablers or inhibitors, of incremental innovation and agility
by: Viljoen, Phlippie
Published: (2016) -
Enabling financial inclusion for the unbanked : in pursuit of a regulatory framework for mobile money in Uganda
by: Nampewo, Joanita Serwanja
Published: (2018) -
Business model innovation : the drivers, enablers and inhibitors of firms facing disruptive change
by: Mudaly, Nicolette Andrea
Published: (2017) -
The impact of merger and acquisition activity on listed innovation driven businesses : Insights from the pharmaceutical and biotechnological industries
by: Zigomo, Tinashe
Published: (2016)